Companies: 48,687 Total Market Cap: 125800178376592.40

Johnson & Johnson

NYSE: JNJ
Healthcare Drug Manufacturers - General
Rank #23
Market Cap 371.64 B
Volume 7.33 M
Price 154.46
Change (%) 1.18%
Country or region United States United States

Johnson & Johnson's latest marketcap:

371.64 B

As of May 2, 2025, Johnson & Johnson's market capitalization has reached $371.64 B. According to our data, Johnson & Johnson is the 23th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 371.64 B
Revenue (ttm) 89.33 B
Net Income (ttm) 21.81 B
Shares Out 2.41 B
EPS (ttm) 8.98
Forward PE 14.65
Ex-Dividend Date May 27, 2025
Earnings Date April 15, 2025
Market Cap Chart
Data Updated: May 2, 2025

Johnson & Johnson's yearly market capitalization.

Johnson & Johnson has seen its market value grow from $180.14 B to $371.93 B since 2001, representing a total increase of 106.47% and an annual compound growth rate (CAGR) of 3.16%.
Date Market Cap Change (%)
April 25, 2025 $371.93 B 6.82%
December 31, 2024 $348.19 B -7.72%
December 29, 2023 $377.32 B -18.3%
December 30, 2022 $461.85 B 2.55%
December 31, 2021 $450.36 B 8.7%
December 31, 2020 $414.31 B 7.92%
December 31, 2019 $383.91 B 10.92%
December 31, 2018 $346.11 B -7.79%
December 29, 2017 $375.36 B 19.76%
December 30, 2016 $313.43 B 10.28%
December 31, 2015 $284.22 B -2.9%
December 31, 2014 $292.70 B 13.27%
December 31, 2013 $258.42 B 33.02%
December 31, 2012 $194.27 B 8.47%
December 30, 2011 $179.09 B 5.44%
December 31, 2010 $169.86 B -4.42%
December 31, 2009 $177.71 B 7.05%
December 31, 2008 $166.00 B -13.03%
December 31, 2007 $190.88 B -0.28%
December 29, 2006 $191.42 B 7.06%
December 30, 2005 $178.79 B -5%
December 31, 2004 $188.21 B 22.75%
December 31, 2003 $153.33 B -3.9%
December 31, 2002 $159.55 B -11.43%
December 31, 2001 $180.14 B

Company Profile

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, is a global leader in healthcare, specializing in research, development, manufacturing, and sales of a diverse range of medical products. Founded in 1886 and headquartered in New Brunswick, New Jersey, the company operates in two key segments:

Innovative Medicine

This segment focuses on therapeutic solutions across multiple medical fields, including:

  • Immunology: Treatments for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis.
  • Infectious Diseases: Solutions for HIV/AIDS and other infectious conditions.
  • Neuroscience: Therapies for mood disorders, neurodegenerative diseases, and schizophrenia.
  • Oncology: Products targeting prostate cancer, hematologic malignancies, lung cancer, and bladder cancer.
  • Cardiovascular & Metabolism: Treatments for thrombosis, diabetes, and macular degeneration.
  • Pulmonary Hypertension: Solutions for pulmonary arterial hypertension.

These products are distributed through retailers, wholesalers, hospitals, and healthcare professionals.

MedTech

This segment provides advanced medical technologies, including:

  • Electrophysiology: Products for heart rhythm disorders.
  • Heart Recovery: Technologies for severe coronary artery disease and cardiogenic shock.
  • Circulatory Restoration: Solutions for calcified coronary and peripheral artery diseases.
  • Neurovascular Care: Treatments for hemorrhagic and ischemic stroke.
  • Orthopedics: Products for hips, knees, trauma, spine, and sports medicine.
  • Surgery: Advanced and general surgery technologies, including breast aesthetics and reconstruction.
  • Vision Care: ACUVUE contact lenses and TECNIS intraocular lenses for cataract surgery.

These offerings are distributed to hospitals, clinics, eye care professionals, and other healthcare providers.

Johnson & Johnson remains a trusted name in healthcare, delivering innovative solutions to improve patient outcomes worldwide.

Frequently Asked Questions

As of May 2, 2025, Johnson & Johnson (including the parent company, if applicable) has an estimated market capitalization of $371.64 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Johnson & Johnson global market capitalization ranking is approximately 23 as of May 2, 2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region United States
Founded 1886
IPO Date n/a
Employees 138,100
CEO Joaquin Duato
Sector Healthcare
Industry Drug Manufacturers - General
Address One Johnson & Johnson Plaza
New Brunswick, New Jersey 08933
United States